Viewing Study NCT03697304


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-02-02 @ 6:20 AM
Study NCT ID: NCT03697304
Status: COMPLETED
Last Update Posted: 2025-01-17
First Post: 2018-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Platform Trial Evaluating Safety and Efficacy of BI 754091 Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1381-0009
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators